Study Stopped
Low accrual
Measuring the Effect of Radiation Therapy on Patient Activity Levels
1 other identifier
observational
32
1 country
2
Brief Summary
The goal of this study is to measure the effect of radiation therapy on the activity levels of patients. This will be achieved by tracking their activity levels during a treatment course of radiation therapy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jul 2015
Typical duration for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2015
CompletedFirst Submitted
Initial submission to the registry
January 27, 2016
CompletedFirst Posted
Study publicly available on registry
February 29, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2018
CompletedAugust 9, 2018
August 1, 2018
3 years
January 27, 2016
August 7, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
Activity level
Misfit activity tracking devices (accelerometers) will be worn by patients to track their activity levels 1 day to 4 weeks before radiotherapy, during radiotherapy, and for 1 day to 4 weeks after radiotherapy.
up to 15 weeks
Study Arms (4)
Head and Neck
Subjects with head and neck cancer receiving radiation therapy.
Prostate
Subjects with prostate cancer receiving radiation therapy.
Breast
Subjects with breast cancer receiving radiation therapy.
Lung
Subjects with lung cancer receiving radiation therapy.
Eligibility Criteria
Potential subjects are initially referred to the Department of Radiation Oncology for their primary cancer diagnosis. Subjects that fit the diagnosis for this study may be offered participation.
You may qualify if:
- Diagnosis of Breast, Prostate, Lung or Head and Neck Cancer
- Eastern Cooperative Oncology Group (ECOG) performance status of 0-1
- Ability to walk 100 feet without rest
- Signed informed consent
You may not qualify if:
- Any other noncutaneous cancer diagnosis under active treatment
- Known metastatic disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
UPMC St. Margaret Department of Radiation Oncology
Pittsburgh, Pennsylvania, 15215, United States
UPMC Shadyside Department of Radiation Oncology
Pittsburgh, Pennsylvania, 15232, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Colin Champ, MD
UPMC Department of Radiation Oncology
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- OTHER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Clinical Professor University of Pittsburgh Radiation Oncology
Study Record Dates
First Submitted
January 27, 2016
First Posted
February 29, 2016
Study Start
July 1, 2015
Primary Completion
July 1, 2018
Study Completion
July 1, 2018
Last Updated
August 9, 2018
Record last verified: 2018-08
Data Sharing
- IPD Sharing
- Will not share